What is Comprehensive CGx Panel?
MoonMD’s Full Comprehensive Cancer Panel is designed to identify genetic factors linked to hereditary cancers such as breast, ovarian, colon, prostate, and skin (melanoma) cancers, along with other inherited cancer types. This advanced panel detects genetic mutations and variants passed from parents to offspring that are known to increase cancer risk. By understanding your genetic predisposition, you and your healthcare provider can take proactive steps—enabling early detection, preventive care, and personalized treatment planning to better safeguard your long-term health.
How Will I Benefit?
To effectively treat cancer, it must first be accurately identified—including its origin and genetic makeup. Certain genetic variants are linked to higher risks for specific cancers, making this information crucial for both prevention and treatment. MoonMD’s Comprehensive Cancer Panel enables early diagnosis, a key factor in successful outcomes, and helps identify individuals with hereditary cancer susceptibility who may benefit from enhanced monitoring and preventive care. Understanding the specific genes involved guides personalized medical management, helping avoid unnecessary follow-ups and improving treatment precision.
If a pathogenic variant is detected, close relatives—such as children, siblings, or parents—may carry up to a 50% increased risk, emphasizing the importance of family-wide genetic awareness and early screening, in some cases beginning during childhood.
What We Offer
MoonMD’s Comprehensive Cancer Testing helps assess your genetic risk for hereditary cancers, including breast, ovarian, colon, prostate, melanoma, and other inherited types. By analyzing 193 genes linked to increased cancer susceptibility, this test identifies genetic variants that may raise your risk—empowering you to take preventive action and make informed healthcare decisions.
Early detection through MoonMD’s Cancer Panel supports timely diagnosis and targeted treatment, improving outcomes and guiding personalized care. If a hereditary risk is found, family members may also benefit from early screening and proactive monitoring to reduce future cancer risks.
